Jensen Investment Management Inc. grew its position in Genpact Limited (NYSE:G - Free Report) by 6.4% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 189,985 shares of the business services provider's stock after buying an additional 11,410 shares during the period. Jensen Investment Management Inc. owned 0.11% of Genpact worth $7,449,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Janney Montgomery Scott LLC acquired a new position in Genpact during the 1st quarter valued at about $703,000. Empowered Funds LLC purchased a new position in shares of Genpact in the 1st quarter valued at approximately $1,937,000. Concurrent Investment Advisors LLC boosted its stake in Genpact by 25.5% in the 1st quarter. Concurrent Investment Advisors LLC now owns 23,352 shares of the business services provider's stock worth $769,000 after purchasing an additional 4,748 shares in the last quarter. Headlands Technologies LLC grew its position in Genpact by 2,366.8% during the 1st quarter. Headlands Technologies LLC now owns 5,057 shares of the business services provider's stock worth $167,000 after purchasing an additional 4,852 shares during the last quarter. Finally, QRG Capital Management Inc. grew its position in Genpact by 6.5% during the 1st quarter. QRG Capital Management Inc. now owns 58,432 shares of the business services provider's stock worth $1,925,000 after purchasing an additional 3,589 shares during the last quarter. Hedge funds and other institutional investors own 96.03% of the company's stock.
Genpact Price Performance
G stock traded up $4.13 during mid-day trading on Friday, reaching $45.94. 3,649,569 shares of the company's stock were exchanged, compared to its average volume of 780,107. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.89 and a quick ratio of 1.89. Genpact Limited has a 12-month low of $29.41 and a 12-month high of $47.98. The stock's 50 day moving average is $39.03 and its 200 day moving average is $35.57. The company has a market cap of $8.19 billion, a price-to-earnings ratio of 12.62, a price-to-earnings-growth ratio of 1.69 and a beta of 1.13.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The business services provider reported $0.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.64 by $0.05. The firm had revenue of $1.18 billion for the quarter, compared to analysts' expectations of $1.15 billion. Genpact had a net margin of 14.12% and a return on equity of 22.28%. On average, research analysts expect that Genpact Limited will post 2.85 EPS for the current year.
Genpact Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, December 23rd. Stockholders of record on Monday, December 9th will be paid a dividend of $0.1525 per share. The ex-dividend date is Monday, December 9th. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.33%. Genpact's dividend payout ratio is currently 16.76%.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on the stock. BMO Capital Markets lifted their price objective on shares of Genpact from $38.00 to $42.00 and gave the stock a "market perform" rating in a research note on Monday, August 12th. TD Cowen increased their price objective on Genpact from $40.00 to $45.00 and gave the company a "hold" rating in a report on Friday. Robert W. Baird increased their price objective on shares of Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a research note on Friday. Jefferies Financial Group lifted their price objective on Genpact from $35.00 to $40.00 and gave the company a "hold" rating in a research note on Monday, September 9th. Finally, JPMorgan Chase & Co. upped their target price on Genpact from $35.00 to $43.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Eight equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, Genpact has an average rating of "Hold" and an average target price of $40.89.
Check Out Our Latest Stock Analysis on Genpact
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
